Newsroom

Sorted by: Latest

-

SABA Announces Notification of Sources of Distributions

NEW YORK--(BUSINESS WIRE)--Saba Capital Income & Opportunities Fund II (NYSE: SABA) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of th...
-

BRW Announces Notification of Sources of Distributions

NEW YORK--(BUSINESS WIRE)--Saba Capital Income & Opportunities Fund (NYSE: BRW) (the “Fund”), a registered closed-end management investment company listed on the New York Stock Exchange, is notifying shareholders, prospective shareholders, and third parties of the sources of distributions pursuant to Section 19(a) of the Investment Company Act of 1940 (the “Investment Company Act”). IMPORTANT INFORMATION REGARDING MONTHLY DISTRIBUTION Distribution Notice. Pursuant to Section 19(a) of the In...
-

OpenSea Adds Support for Solana NFTs, Extending Its Marketplace

MIAMI--(BUSINESS WIRE)--OpenSea, one of the world's largest digital asset platforms, today announced support for Solana NFTs, enabling users to buy, sell, and trade Solana-based NFTs using OpenSea. With its support for Solana, users can now find and trade popular Solana NFT collections, including Claynosaurz, Mad Lads, BoDoggos, Collector Crypt, Phygitals, and others. "OpenSea should be the home for everything you collect, no matter which chain it lives on," said Devin Finzer, co-founder and CE...
-

Karman Space & Defense to Participate in Upcoming Investor Conferences

HUNTINGTON BEACH, Calif.--(BUSINESS WIRE)--Karman Space & Defense to Participate in Upcoming Investor Conferences...
-

Ares Closes Fifth Japan Logistics Real Estate Development Fund at ¥612 Billion (US$4 Billion), Hitting Hard Cap

NEW YORK & TOKYO--(BUSINESS WIRE)--Ares Management Corporation (NYSE: ARES) (“Ares”), a leading global alternative investment manager, announced today the final close of Japan Logistics Development Partners V LP (“JDP V” or the “Fund”), the latest vintage in its Japan-focused logistics real estate development fund series. Raising ¥612 billion (approximately US$4 billion1), including LP equity commitments and GP commitment, JDP V closed at its hard cap and is nearly 50% larger than its predecess...
-

Domo Announces Timing for Second Quarter Fiscal 2027 Financial Results and Provides Transaction Timing Update

SILICON SLOPES, Utah--(BUSINESS WIRE)--Domo, Inc. (Nasdaq: DOMO) (“Domo” or the “Company”) today announced that it expects to file its Quarterly Report on Form 10-Q for its second quarter ended July 31, 2026, on Thursday, September 3, 2026, after the market closes. Domo will report its quarterly financial results through the Form 10-Q and does not plan to issue a separate earnings release. Due to the pending transaction with Progress Software Corporation (Nasdaq: PRGS) (“Progress”), the company...
-

2026 Avetta Summit Series Lands in Sydney to Unite Trusted APAC Community Committed to Being Ready to Work

SYDNEY--(BUSINESS WIRE)--Avetta®, the leader in intelligent work readiness across global supply chains, today revealed new details about its 2026 Summit Series event taking place in Sydney on 10 September 2026. That includes an all-new format focused on a curated experience designed to go beyond traditional conferences and drive meaningful outcomes for its community of hiring clients, suppliers, contractors and partners across APAC. Avetta also outlined keynote speakers, previewed forthcoming re...
-

AN2 Therapeutics Presents Clinical and Translational Data Supporting Development of Epetraborole for Polycythemia Vera at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting

MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical stage biopharmaceutical company focused on the discovery and development of novel small molecule therapeutics derived from its boron chemistry platform, today announced that four abstracts highlighting clinical and nonclinical data supporting the development of epetraborole, a novel boron-containing oral candidate for the treatment of polycythemia vera (PV), will be presented at the Society of Hematologic Onc...
-

Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR T cell and in vivo CAR T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced it granted an inducement award on August 31, 2026. One individual was hired by Adicet in August 2026 and granted new hire non-qualified stock options to purchase 1,500 shares of Adicet’s common stock with an exercis...
-

Strategic Combination of ITC Infotech and Happiest Minds Technologies to Create a Scaled, Future-Ready, AI-First Global Technology Services Enterprise with US$ 1 Billion Revenue by FY28[1]

BANGALORE, India--(BUSINESS WIRE)--ITC Infotech–Happiest Minds Strategic Combination to Create a Scaled, AI-First Global Technology Services Enterprise....